Durchbrechung von Tumortoleranz durch allogene HLA-idente T-Zellen (A13)

• Subject Area: Hematology, Oncology
• Term: from 2003 to 2008
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 5480425

No abstract available

• DFG Programme: Collaborative Research Centres
• Subproject of: SFB 432: Mechanism of Tumor Defense and their Therapeutic Implications
• Applicant Institution: Johannes Gutenberg-Universität Mainz
• Co-Applicant Institution: Goethe-Universität Frankfurt am Main
• Project Heads: Professor Dr. Wolfgang Herr; Professor Dr. Michael Karas